Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Cancer Research UK
Cancer Research UK
Activities:
Research & Development
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Lonza’s capsule delivers acid-sensitive ingredients to the intestine
The capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Study demonstrates way to target hard-to-treat cancer mutation
The study was funded by Cancer Research UK and Wellcome
Research & Development
Aptamer and Cancer Research UK collaborate for drug discovery
The project will explore aptamers as therapeutic agents for the treatment of Chronic Myelomonocytic Leukaemia and other myeloid malignancies
Finance
Research funding round-up
Capital to support the development of new drugs and technology around the world
Research & Development
Oesophageal cancer genes leads to new drug targets
Mutations that cause oesophageal adenocarcinoma have been mapped unveiling that more than half could be targeted by drugs currently in trials for other cancer types.
Regulatory
Clinical trial launches to develop breath test for multiple cancers
Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage
Research & Development
Cancer Research UK and AstraZeneca launch functional genomics centre
The centre will be a dedicated resource for AstraZeneca and Cancer Research UK’s academics and alliance partners working at all stages of translational research
Regulatory
Patients could lose out on life-saving treatments
Limited access to novel therapies could hinder effective personalised cancer treatment in the UK, says GlobalData
Subscribe now